{"schema_version":"secwatch.filing_event.v1","accession":"0000711404-25-000036","form_type":"8-K","ticker":"COO","cik":"0000711404","company_name":"COOPER COMPANIES, INC.","filed_at":"2025-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.071306+00:00","generated_at":"2026-05-20T07:08:25.509384+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CooperCompanies Q2 revenue $1.00B, up 6% YoY; non-GAAP EPS $0.96 (+14%)","bullets":["Revenue $1,002.3M (+6% YoY); GAAP EPS $0.44 flat; non-GAAP EPS $0.96 (+14%).","CooperVision revenue $669.6M (+5% reported, +7% organic); CooperSurgical $332.7M (+8% reported, +7% organic).","FY2025 guidance: total revenue $4,107-4,146M (organic +5-6%), non-GAAP EPS $4.05-4.11.","Q2 share repurchases $40.6M (~537k shares at avg $75.60); $215.8M remaining in program.","Gross margin improved to 68% (GAAP/non-GAAP) from 67% YoY; operating margin 18% GAAP, 25% non-GAAP."],"urls":{"canonical":"https://secwatch.observer/filing/0000711404-25-000036","json":"https://secwatch.observer/filing/0000711404-25-000036.json","markdown":"https://secwatch.observer/filing/0000711404-25-000036.md","text":"https://secwatch.observer/filing/0000711404-25-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711404/000071140425000036/0000711404-25-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711404/000071140425000036/coo-20250529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T07:08:25.509384+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}